Restricting HIV-1 infection
Vanderbilt University Medical Center Research News Sep 07, 2017
The HIV–1 capsid protein (CA) interacts with viral factors that support infection and host factors that restrict it. The host protein cyclophilin A (CypA) binds to CA and enhances the action of host restriction factors that block HIV–1 infection.
Christopher Aiken, PhD, and colleagues investigated how CypA potentiates the action of the restriction factor TRIM5alpha in African green monkey cells. They did not find evidence of a role for CypA in promoting binding of TRIM5alpha to the viral capsid or inhibiting reverse transcription of the viral genome.
Instead, the investigators observed a CypA–dependent reduction in the accumulation of nuclear HIV–1 DNA, suggesting that CypA promotes TRIM5alpha inhibition of HIV–1 nuclear import.
They reported their findings in the journal PLOS ONE.
The authors propose that CypA uses a common mechanism involving interactions of the virus with nuclear pore components to potentiate restriction of HIV–1 infection by TRIM5alpha and other capsid–targeting inhibitors.
Go to Original
Christopher Aiken, PhD, and colleagues investigated how CypA potentiates the action of the restriction factor TRIM5alpha in African green monkey cells. They did not find evidence of a role for CypA in promoting binding of TRIM5alpha to the viral capsid or inhibiting reverse transcription of the viral genome.
Instead, the investigators observed a CypA–dependent reduction in the accumulation of nuclear HIV–1 DNA, suggesting that CypA promotes TRIM5alpha inhibition of HIV–1 nuclear import.
They reported their findings in the journal PLOS ONE.
The authors propose that CypA uses a common mechanism involving interactions of the virus with nuclear pore components to potentiate restriction of HIV–1 infection by TRIM5alpha and other capsid–targeting inhibitors.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
